Gen terapisi, yaşlı parkinsonlu erkek ve dişi makaklardaki motor engelliliği tersine çevirir.
Gene therapy downregulating CaV1.3 reverses motor disability in aged parkinsonian male and female macaques.
DOI: 10.1016/j.ymthe.2025.07.049PMID: 40782791
Gene therapy downregulating CaV1.3 reverses motor disability in aged parkinsonian male and female macaques.
DOI: 10.1016/j.ymthe.2025.07.049PMID: 40782791
Clinical Study of Drug Therapy Combined With Scraping in Patients With Primary Parkinson Disease.
DOI: 10.1097/wnf.0000000000000648PMID: 40844384
TRPM8 modulation alters uptake of Transferrin-mediated Fe<sup>3+</sup>, mitochondrial Fe<sup>2+</sup> and intracellular Ca<sup>2+</sup>-levels in microglia.
DOI: 10.1016/j.neuint.2025.106031PMID: 40784409
Detection of D-Dopa in levodopa tablets by derivatization coupled with LC-MS/MS.
DOI: 10.1016/j.chroma.2025.466278PMID: 40818435
Leveraging open cheminformatics tools for non-targeted metabolomics analysis of C. elegans: a workflow comparison and application to strains related to xenobiotic metabolism and neurodegeneration.
DOI: 10.1007/s00216-025-06048-yPMID: 40775120
Probabilistic Mapping of Magnetic Resonance-Guided Focused Ultrasound (MRgFUS) Thalamotomy Targets in Essential Tremor and Tremor-Dominant Parkinson's Disease: Insights from a German Cohort.
DOI: 10.1002/mds.70003PMID: 40778498
Immunity in Parkinson's disease - The role of innate responses.
DOI: 10.1016/j.jneuroim.2025.578716PMID: 40840360
DWT-OEFS: discrete wavelet transform based optimized ensemble feature selection for Parkinson's disease severity classification.
DOI: 10.1007/s11571-025-10312-3PMID: 40786005
Clinical Benefits of Reprogramming Chronic Subthalamic Stimulation in Parkinson's Disease.
DOI: 10.1002/mdc3.70281PMID: 40879710
Immunohistochemical characterisation of dopaminergic and cholinergic alterations in the prefrontal cortex and hippocampus of MPTP-treated marmosets.
DOI: 10.1080/00207454.2025.2540288PMID: 40776717
Vascularized midbrain assembloids show neuroinflammation and dopaminergic neuron vulnerability in Parkinson’s Disease
DOI: 10.1101/2025.08.06.668815
Fall Frequency, Risk Factors, and Outcomes in Parkinson’s Disease: A Cross-Sectional Analysis
DOI: 10.1101/2025.08.05.25332959
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.